123 related articles for article (PubMed ID: 7509750)
1. Interleukin-1 contributes to the induction of nitric oxide synthase by endotoxin in vivo.
Szabó C; Wu CC; Gross SS; Thiemermann C; Vane JR
Eur J Pharmacol; 1993 Nov; 250(1):157-60. PubMed ID: 7509750
[TBL] [Abstract][Full Text] [Related]
2. Attenuation of the induction of nitric oxide synthase by endogenous glucocorticoids accounts for endotoxin tolerance in vivo.
Szabó C; Thiemermann C; Wu CC; Perretti M; Vane JR
Proc Natl Acad Sci U S A; 1994 Jan; 91(1):271-5. PubMed ID: 7506416
[TBL] [Abstract][Full Text] [Related]
3. Nitric oxide-mediated hyporeactivity to noradrenaline precedes the induction of nitric oxide synthase in endotoxin shock.
Szabó C; Mitchell JA; Thiemermann C; Vane JR
Br J Pharmacol; 1993 Mar; 108(3):786-92. PubMed ID: 7682137
[TBL] [Abstract][Full Text] [Related]
4. Role of tumour necrosis factor in the induction of nitric oxide synthase in a rat model of endotoxin shock.
Thiemermann C; Wu CC; Szabó C; Perretti M; Vane JR
Br J Pharmacol; 1993 Sep; 110(1):177-82. PubMed ID: 7693276
[TBL] [Abstract][Full Text] [Related]
5. Pentoxifylline improves circulatory failure and survival in murine models of endotoxaemia.
Wu CC; Liao MH; Chen SJ; Yen MH
Eur J Pharmacol; 1999 May; 373(1):41-9. PubMed ID: 10408250
[TBL] [Abstract][Full Text] [Related]
6. Glibenclamide-induced inhibition of the expression of inducible nitric oxide synthase in cultured macrophages and in the anaesthetized rat.
Wu CC; Thiemermann C; Vane JR
Br J Pharmacol; 1995 Mar; 114(6):1273-81. PubMed ID: 7542532
[TBL] [Abstract][Full Text] [Related]
7. Tetramethylpyradizine prevents inducible NO synthase expression and improves survival in rodent models of endotoxic shock.
Wu CC; Liao MH; Chen SJ; Yen MH
Naunyn Schmiedebergs Arch Pharmacol; 1999 Oct; 360(4):435-44. PubMed ID: 10551281
[TBL] [Abstract][Full Text] [Related]
8. Delayed circulatory failure due to the induction of nitric oxide synthase by lipoteichoic acid from Staphylococcus aureus in anaesthetized rats.
De Kimpe SJ; Hunter ML; Bryant CE; Thiemermann C; Vane JR
Br J Pharmacol; 1995 Mar; 114(6):1317-23. PubMed ID: 7542534
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological characterization of guanidinoethyldisulphide (GED), a novel inhibitor of nitric oxide synthase with selectivity towards the inducible isoform.
Szabó C; Bryk R; Zingarelli B; Southan GJ; Gahman TC; Bhat V; Salzman AL; Wolff DJ
Br J Pharmacol; 1996 Aug; 118(7):1659-68. PubMed ID: 8842429
[TBL] [Abstract][Full Text] [Related]
10. Vascular hyporeactivity to vasoconstrictor agents and hemodynamic decompensation in hemorrhagic shock is mediated by nitric oxide.
Thiemermann C; Szabó C; Mitchell JA; Vane JR
Proc Natl Acad Sci U S A; 1993 Jan; 90(1):267-71. PubMed ID: 7678341
[TBL] [Abstract][Full Text] [Related]
11. Role of endotoxin in L-arginine-induced relaxation of rat thoracic aorta mediated by muscle-derived nitric oxide.
Moritoki H; Takeuchi S; Kondoh W; Hisayama T; Hashizume M; Noda K
Arch Int Pharmacodyn Ther; 1994; 327(2):152-65. PubMed ID: 7526814
[TBL] [Abstract][Full Text] [Related]
12. Aminoguanidine attenuates the delayed circulatory failure and improves survival in rodent models of endotoxic shock.
Wu CC; Chen SJ; Szabó C; Thiemermann C; Vane JR
Br J Pharmacol; 1995 Apr; 114(8):1666-72. PubMed ID: 7541282
[TBL] [Abstract][Full Text] [Related]
13. Effect of tyrosine kinase and tyrosine phosphatase inhibitors on aortic contraction and induction of nitric oxide synthase.
Duarte J; Ocete MA; Pérez-Vizcaino F; Zarzuelo A; Tamargo J
Eur J Pharmacol; 1997 Oct; 338(1):25-33. PubMed ID: 9408000
[TBL] [Abstract][Full Text] [Related]
14. In vivo administration of endotoxin and tumor necrosis factor-alpha produce different effects on constitutive and inducible nitric oxide synthase activity in rat neutrophils and aorta ex vivo.
Greenberg SS; Xie J; Joseph KO; Kolls J; Summer W
Proc Soc Exp Biol Med; 1995 Feb; 208(2):199-208. PubMed ID: 7530365
[TBL] [Abstract][Full Text] [Related]
15. Thaliporphine selectively inhibits expression of the inducible, but not the constitutive, nitric oxide synthase.
Yu SM
Biochem J; 1994 Oct; 303 ( Pt 1)(Pt 1):289-94. PubMed ID: 7524482
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of interleukin-1-alpha-induced nitric oxide synthase in vascular smooth muscle and full reversal of interleukin-1-alpha-induced hypotension by N omega-amino-L-arginine.
Kilbourn RG; Gross SS; Lodato RF; Adams J; Levi R; Miller LL; Lachman LB; Griffith OW
J Natl Cancer Inst; 1992 Jul; 84(13):1008-16. PubMed ID: 1376778
[TBL] [Abstract][Full Text] [Related]
17. Anti-inflammatory glucocorticoids inhibit the induction by endotoxin of nitric oxide synthase in the lung, liver and aorta of the rat.
Knowles RG; Salter M; Brooks SL; Moncada S
Biochem Biophys Res Commun; 1990 Nov; 172(3):1042-8. PubMed ID: 1700903
[TBL] [Abstract][Full Text] [Related]
18. Aminoguanidine reverses aortic hyporeactivity to noradrenaline in portal vein-ligated rats.
Michielsen PP; Boeckxstaens GE; Sys SU; Herman AG; Pelckmans PA
Eur J Pharmacol; 1997 Jun; 329(2-3):137-46. PubMed ID: 9226406
[TBL] [Abstract][Full Text] [Related]
19. Nitric oxide-independent activation of soluble guanylyl cyclase contributes to endotoxin shock in rats.
Wu CC; Chen SJ; Yen MH
Am J Physiol; 1998 Oct; 275(4):H1148-57. PubMed ID: 9746461
[TBL] [Abstract][Full Text] [Related]
20. Pyrrolidine dithiocarbamate selectively prevents the expression of the inducible nitric oxide synthase in the rat aorta.
Schini-Kerth V; Bara A; Mülsch A; Busse R
Eur J Pharmacol; 1994 Nov; 265(1-2):83-7. PubMed ID: 7533726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
